H. Grote

5.7k citations

60 papers · 2.5k indexed · 2 hit papers · h-index 26

Impact in

Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction

Papers in

Oncology 20
- Cancer Immunotherapy and Biomarkers 8
- Polyomavirus and related diseases 6
Nuclear and High Energy Physics 8
- Particle Detector Development and Performance 5

Co-authors: Anja von Heydebreck Kevin M. Chin James L. Gulley Erika Hamilton W. Jeff Edenfield Alfred Böcking Karen Kelly Jayne S. Gurtler
Journals: Journal of Clinical Oncology (9 papers)Cancer (3 papers)Diagnostic Cytopathology (2 papers)International Journal of Cancer (2 papers)JAMA Oncology (2 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

H. Grote

59 papers receiving 2.5k citations

Hit Papers

align trajectories log scale

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer 2019 · 319 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 JAMA Oncology
2017 Breast Cancer Research and Treatment

Peers

Countries citing papers authored by H. Grote

Since Specialization

Citations

This map shows the geographic impact of H. Grote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Grote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Grote more than expected).

Fields of papers citing papers by H. Grote

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Grote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Grote. The network helps show where H. Grote may publish in the future.

Co-authorship network

The 25 scholars most cited alongside H. Grote, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. Grote Line = papers co-authored together H. Grote links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study Journal for ImmunoTherapy of Cancer ·Claire F. Verschraegen, Guy Jérusalem, Edward F. McClay, Nicholas Iannotti, Charles H. Redfern, Jaafar Bennouna, Liya Lin, Karen Kelly, Janice M. Mehnert, John C. Morris, Matthew H. Taylor, David R. Spigel, Ding Wang, H. Grote, Dongli Zhou, Neru Munshi, Marcis Bajars, James L. Gulley	2020	19
2	Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma Frontiers in Medicine ·Glenn J. Hanna, Alec Kacew, Hemilly Franklin Alves, H. Grote, Sathit Pasomsub, Beatrice Brunkhorst, Guilherme Rabinowits, Manisha Thakuria, Nicole R. LeBoeuf, Christian Ihling, James A. DeCaprio, Jochen H. Lorch	2020	5
3	PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters PLoS ONE ·Manuel A. Silva, Karen A. Ryall, Claudia Wilm, Э Б Ягубский, H. Grote, Janet C. Patterson‐Kane	2018	19
4	Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study Breast Cancer Research and Treatment ·Luc Dirix, István Takács, Guy Jérusalem, Petros Nikolinakos, Hendrik‐Tobias Arkenau, Andres Forero‐Torres, Ralph V. Boccia, Marc E. Lippman, Robert A. Somer, Martin Šmakal, Leisha A. Emens, Borys Hrinczenko, W. Jeff Edenfield, Jayne S. Gurtler, Anja von Heydebreck, H. Grote, Kevin M. Chin, Erika Hamilton Hit paper breakdown →	2017	581
5	Avelumab in patients with metastatic adrenocortical carcinoma (mACC): Results from the JAVELIN solid tumor trial Annals of Oncology ·C. Le Tourneau, Corrine Zarwan, Christopher Hoimes, Deborah J. Wong, Sebastian Bauer, Martin Wermke, H. Grote, Anja von Heydebreck, Kevin M. Chin, James L. Gulley	2017	3
6	Early cytological diagnosis of diffuse malignant mesothelioma of the peritoneum: A case report Diagnostic Cytopathology ·Natalia Pomjanski, H. Grote, Oliver Sander, Sebastian Heikaus, Klaus‐Michael Müller, Alfred Böcking	2008	9
7	9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis Cancer ·Lindsay M. Chervinsky, Alexandre Sherlley Casimiro Onofre, Natalia Pomjanski, Albert Nailevich Valiakhmetov, H. Grote, Alfred Böcking	2008	47
8	Quantitative methylierungsspezifische PCR zur Lungenkarzinomdiagnostik Der Pathologe ·H. Grote, Viola Schmiemann, Eduardo Martinez Sanchez, Alfred Böcking	2007	2
9	Methylation of RAS association domain family protein 1A as a biomarker of lung cancer Cancer ·H. Grote, Viola Schmiemann, Helene Geddert, Alfred Böcking, A. W., Helmut E. Gabbert, Mario Sarbia	2006	39
10	Aberrant promoter methylation ofp16INK4a,RARB2 andSEMA3B in bronchial aspirates from patients with suspected lung cancer International Journal of Cancer ·H. Grote, Viola Schmiemann, Helene Geddert, Rafael Antonio Gutiérrez Martínez, A. W., Helmut E. Gabbert, Alfred Böcking	2005	48
11	Immunocytochemical identification of carcinomas of unknown primary in serous effusions Diagnostic Cytopathology ·Natalia Pomjanski, H. Grote, Guoxiang Sun, Viola Schmiemann, Albert Nailevich Valiakhmetov, Alfred Böcking	2005	36
12	Spontaneous malignant transformation of conventional giant cell tumor Skeletal Radiology ·H. Grote, Marcin Braun, Thomas Kalinski, Natalia Pomjanski, Walter Back, U. Bleyl, S. Schlensthdt, Albert Roessner	2004	31
13	Identification of progressive cervical epithelial cell abnormalities using DNA image cytometry Cancer ·H. Grote, Vũ Quốc Huy Nguyễn, Paméla Olson, Alfred Böcking	2004	29
14	Floating aortic thrombus in systemic aspergillosis and detection by transesophageal echocardiography Critical Care Medicine ·Frank Grothues, Tobias Welte, H. Grote, Albert Roessner, Helmut Klein	2002	20
15	Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·H. Grote, Regine Schneider‐Stock, W. Neumann, Albert Roessner	2000	29
16	A Robust and Flexible Lattice for LHC J. P. Koutchouk, A. Faus‐Golfe, H. Grote, T. Risselada, A. Verdier, S. Weisz	1997	2
17	Intervertebral variation in trabecular microarchitecture throughout the normal spine in relation to age Bone ·H. Grote, Michael Amling, M. Vogel, Michael Hahn, M Pösl, G. Delling	1995	87
18	Three-dimensional analysis of the spine in autopsy cases with renal osteodystrophy Kidney International ·Michael Amling, H. Grote, J. W. Giltay, Michael E. Hahn, G. Delling	1994	46
19	Polyostotic heterogeneity of the spine in osteoporosis. Quantitative analysis and three-dimensional morphology Bone and Mineral ·Jeffery B. Snipes, H. Grote, M Pösl, Michael E. Hahn, G. Delling	1994	42
20	Applied software for wire chambers Nuclear Instruments and Methods ·H. Grote, P. Zanella	1980	1

About H. Grote

H. Grote is a scholar working on Oncology, Nuclear and High Energy Physics, Aerospace Engineering, Oral Surgery and Pulmonary and Respiratory Medicine, having authored 60 papers that have together received 2.5k indexed citations. Recurring topics across this work include Particle Accelerators and Free-Electron Lasers (15 papers), Particle accelerators and beam dynamics (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Superconducting Materials and Applications (7 papers), Polyomavirus and related diseases (6 papers), Occupational and environmental lung diseases (6 papers), Epigenetics and DNA Methylation (6 papers) and Particle Detector Development and Performance (5 papers). The work is most often cited by research in Oncology (1.4k citations), Immunology (509 citations), Pulmonary and Respiratory Medicine (782 citations), Reproductive Medicine (177 citations) and Cancer Research (292 citations). H. Grote has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Anja von Heydebreck, Kevin M. Chin, James L. Gulley, Erika Hamilton, W. Jeff Edenfield, Alfred Böcking, Karen Kelly, Jayne S. Gurtler, Guy Jérusalem and István Takács. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Diagnostic Cytopathology, International Journal of Cancer and JAMA Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact